BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naito S, Yoshio T, Ishiyama A, Tsuchida T, Tokura J, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Hirasawa T, Asari T, Mine S, Watanabe M, Ogura M, Chin K, Fukuzawa M, Itoi T, Fujisaki J. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig Endosc 2022;34:793-804. [PMID: 34599604 DOI: 10.1111/den.14154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Wang L, Shi X, Chen J, Jin Z, Zou D, Li Z, Liu F. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis. Surg Endosc 2023;37:1761-70. [PMID: 36220991 DOI: 10.1007/s00464-022-09683-z] [Reference Citation Analysis]
2 Ohki D, Tsuji Y, Shinozaki T, Sakaguchi Y, Mizutani H, Nagao S, Miura Y, Fukagawa K, Tamura N, Yakabi S, Yamamichi N, Fujishiro M. Long-term prognosis after endoscopic resection of T1a-MM/T1b-SM1 esophageal squamous cell carcinoma. Medicine (Baltimore) 2022;101:e32115. [PMID: 36626416 DOI: 10.1097/MD.0000000000032115] [Reference Citation Analysis]
3 Takahashi S, Hatta W, Watanabe K, Koike T, Shimada T, Hikichi T, Toya Y, Tanaka I, Onozato Y, Hamada K, Fukushi D, Watanabe K, Kayaba S, Ito H, Mikami T, Oikawa T, Takahashi Y, Kondo Y, Yoshimura T, Shiroki T, Nagino K, Hanabata N, Funakubo A, Hirasawa D, Ohira T, Nakamura J, Nakamura T, Nakaya N, Matsumoto T, Fukuda S, Masamune A, Iijima K. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2022. [PMID: 36445654 DOI: 10.1007/s10620-022-07746-8] [Reference Citation Analysis]
4 Dobashi A, Aizawa D, Hara Y, Furuhashi H, Matsui H, Futakuchi T, Ono S, Toyoizumi H, Bazerbachi F, Yamauchi T, Suka M, Sumiyama K. The Advantage of Immunohistochemical Staining for Evaluating Lymphovascular Invasion Is Limited for Patients with Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa. J Clin Med 2022;11. [PMID: 36498543 DOI: 10.3390/jcm11236969] [Reference Citation Analysis]
5 Gao X, Taylor S, Pang W, Hui R, Lu X, Braden B, Allan P, Ambrose T, Arancibia-cárcamo C, Bailey A, Barnes E, Bird-lieberman E, Bornschein J, Brain O, Collier J, Culver E, East J, Geremia A, George B, Howarth L, Jones K, Klenerman P, Leedham S, Palmer R, Powrie F, Rodrigues A, Satsangi J, Simmons A, Travis S, Uhlig H, Walsh A. Fusion of colour contrasted images for early detection of oesophageal squamous cell dysplasia from endoscopic videos in real time. Information Fusion 2022. [DOI: 10.1016/j.inffus.2022.11.023] [Reference Citation Analysis]
6 Yano T. Can endoscopic submucosal dissection be an appropriate initial treatment for T1 esophageal squamous cell carcinoma? Dig Endosc 2022;34:805-7. [PMID: 35486023 DOI: 10.1111/den.14285] [Reference Citation Analysis]
7 Yoshio T. Treatment outcomes of endoscopic resection for esophageal squamous cell carcinoma based on clinical diagnosis. Dig Endosc 2022;34:791-2. [PMID: 35318740 DOI: 10.1111/den.14287] [Reference Citation Analysis]